Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphonopyruvate hydrolase (PPH; EC 3.11.1.3) is a bacterial enzyme that specifically catalyzes the hydrolytic cleavage of the carbon-phosphorus (C–P) bond in 3-phosphonopyruvate, producing pyruvate and phosphate[2][4][7][8]. PPH is highly substrate-specific, requiring phosphonopyruvate, with activity dependent on divalent cations such as Co²⁺, Mg²⁺, and Mn²⁺[2][6][8]. It is part of the phosphoenolpyruvate mutase/isocitrate lyase (PEPM/ICL) superfamily and plays a key role in the microbial degradation of phosphonates, contributing to the biogeochemical cycling of phosphorus in the environment[1][2][3][5]. PPH is not known as a human therapeutic target and has no established drug interactions or disease associations[8]. Its molecular structure is similar to other members of its superfamily, adopting an (α/β)₈ barrel fold, typically forming a tetramer[3][5]. It is chiefly studied for its biochemical mechanisms and environmental significance rather than for direct clinical or pharmacological applications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphonopyruvate hydrolase (PPH).